TerSera to Present Real-World PRIALT Data at ASPN 2025
18 Jul 2025 //
BUSINESSWIRE
Tersera Notes PACC Guidelines Update For PRIALT Administration
23 Jul 2024 //
BUSINESSWIRE
AmbioPharm Inc. Working with University of California Davis to Develop Non-Opioid Peptide-Based Pain Therapeutics
20 Jul 2021 //
PRESS RELEASE
Jazz Pharmaceuticals Enters Into Agreement with TerSera Therapeutics for Prialt
29 Jun 2018 //
PR NEWSWIRE